Literature DB >> 24497039

Comparative analysis of different enzyme immunoassays for assessment of phosphatidylserine-dependent antiprothrombin antibodies.

Olga Amengual1, Tetsuya Horita, Walter Binder, Gary L Norman, Zakera Shums, Masaru Kato, Kotaro Otomo, Yuichiro Fujieda, Kenji Oku, Toshiyuki Bohgaki, Shinsuke Yasuda, Tatsuya Atsumi.   

Abstract

Phosphatidylserine-dependent antiprothrombin antibodies (aPS/PT) were strongly correlated with the presence of lupus anticoagulant showing a high specificity for the diagnosis of antiphospholipid syndrome. However, the main criticism for the clinical applicability of aPS/PT testing is the lack of reproducibility of the results among laboratories. In this study, we measured IgG and IgM aPS/PT using our original in-house enzyme-linked immunosorbent assays (ELISA) and commercial ELISA kits to assess the assay performance and to evaluate the accuracy of aPS/PT results. The study included 111 plasma samples collected from patients and stored at our laboratory for aPS/PT assessment. Sixty-one samples were tested for IgG aPS/PT using two assays: (1) aPS/PT in-house ELISA and (2) QUANTA Lite™ aPS/PT IgG ELISA kit (INOVA Diagnostics, Inc., USA). Fifty samples were evaluated for IgM aPS/PT using two assays: (1) aPS/PT in-house ELISA and (2) QUANTA Lite™ aPS/PT IgM ELISA kit (INOVA Diagnostics). Ninety-eight percent of samples yielded concordant results for IgG aPS/PT and 82 % for IgM aPS/PT. There was an excellent agreement between the IgG aPS/PT assays (Cohen κ = 0.962) and moderate agreement between the IgM aPS/PT assays (κ = 0.597). Statistically significant correlations in the aPS/PT results were obtained from both IgG and IgM aPS/PT assays (r = 0.749, r = 0.622, p < 0.001, respectively). In conclusion, IgG and IgM detection by ELISA is accurate. The performance of aPS/PT is reliable, and concordant results can be obtained using different ELISA methods.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24497039     DOI: 10.1007/s00296-014-2951-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

1.  Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA).

Authors:  V Pengo; G Denas; E Bison; A Banzato; S Padayattil Jose; P Gresele; F Marongiu; N Erba; F Veschi; A Ghirarduzzi; E De Candia; B Montaruli; M Marietta; S Testa; D Barcellona; A Tripodi
Journal:  Thromb Res       Date:  2010-06-09       Impact factor: 3.944

2.  Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.

Authors:  Kotaro Otomo; Tatsuya Atsumi; Olga Amengual; Yuichiro Fujieda; Masaru Kato; Kenji Oku; Tetsuya Horita; Shinsuke Yasuda; Takao Koike
Journal:  Arthritis Rheum       Date:  2012-02

3.  Antiprothrombin antibody: why do we need more assays?

Authors:  T Atsumi; T Koike
Journal:  Lupus       Date:  2010-04       Impact factor: 2.911

4.  'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010.

Authors:  M L Bertolaccini; O Amengual; T Atsumi; W L Binder; B de Laat; R Forastiero; W H Kutteh; M Lambert; H Matsubayashi; V Murthy; M Petri; J H Rand; M Sanmarco; A E Tebo; S S Pierangeli
Journal:  Lupus       Date:  2011-02       Impact factor: 2.911

5.  The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome.

Authors:  A Hoxha; A Ruffatti; M Pittoni; A Bontadi; M Tonello; E Salvan; M Plebani; L Punzi
Journal:  Clin Chim Acta       Date:  2012-02-12       Impact factor: 3.786

Review 6.  Which antiphospholipid antibodies should be measured in the antiphospholipid syndrome?

Authors:  M Galli
Journal:  Haemostasis       Date:  2000

7.  Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome.

Authors:  A Hoxha; A Ruffatti; M Tonello; A Bontadi; E Salvan; A Banzato; V Pengo; L Punzi
Journal:  Lupus       Date:  2012-06       Impact factor: 2.911

8.  GAPSS: the Global Anti-Phospholipid Syndrome Score.

Authors:  Savino Sciascia; Giovanni Sanna; Veronica Murru; Dario Roccatello; Munther A Khamashta; Maria Laura Bertolaccini
Journal:  Rheumatology (Oxford)       Date:  2013-01-12       Impact factor: 7.580

9.  Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I.

Authors:  M J Sanfelippo; A Joshi; Sl Schwartz; J A Meister; J W Goldberg
Journal:  Lupus       Date:  2013-08-29       Impact factor: 2.911

10.  Anti-phosphatidylserine/prothrombin antibodies: an additional diagnostic marker for APS?

Authors:  Francesca Pregnolato; Cecilia B Chighizola; Susan Encabo; Zakera Shums; Gary L Norman; Armando Tripodi; Veena Chantarangkul; Tiziana Bertero; Valeria De Micheli; Maria Orietta Borghi; Pier Luigi Meroni
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.